Strategy

Ten years ago, I testified before Congress about drug pricing — and it’s only gotten worse. Here’s what’s wrong, and how we may be able to fix it.

Jasmin Weaver is the executive vice president of Civic Ventures. She has worked at the state, local, and federal levels developing and implementing policies and overseeing advocacy efforts. She is a rotating co-host of the Pitchfork Economics podcast with Nick Hanauer. She testified before Congress about “out of control prescription […]
Ten years ago, I testified before Congress about drug pricing — and it’s only gotten worse. Here’s what’s wrong, and how we may be able to fix it.
Markets

Mylan tumbles on reported shortages of its life-saving EpiPens

Shares of drugmaker Mylan are sinking after a report from Bloomberg found that the company’s landmark anti-allergy device is in short-supply. The supply of Mylan’s EpiPen has been falling since May 2018, according to the Food and Drug Administration. Parents and pharmacists are doing all they can to get ahold […]
Mylan tumbles on reported shortages of its life-saving EpiPens
News

EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes

People with life-threatening allergies rely on the EpiPen in emergencies. Complaints about EpiPens not working or arriving in bad shape began to mount in 2013 and 2014. The manufacturer, Meridian Medical Technologies, didn’t properly look into those complaints, FDA inspectors warned as far back as 2014. Meridian didn’t make significant […]
EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes
Markets

Mylan stock dropped 7% after second quarter sales slumped

Mylan’s stock dropped 7.4% shortly after markets opened on Wednesday due to poor second quarter earnings. The company’s total revenue for the second quarter was $US2.8 billion, down 5% compared to last year. Sales in North America also fell 22%. Mylan then announced that it was going to conduct a […]
Mylan stock dropped 7% after second quarter sales slumped
Markets

There’s a shortage of EpiPens in the US

The FDA on Wednesdsay said that there’s a shortage of EpiPens in the US. Mylan, the company that distributes the emergency allergy medication, said that there are “intermittent supply constraints,” but supply is available. The issues stem from delays at Pfizer’s Meridian Medical Technologies, which makes the device. There’s a […]
There’s a shortage of EpiPens in the US